OPEN END TURBO OPTIONSSCHEIN SHORT - AMGEN | Market Closed - BOERSE MUENCHEN 14:26:38 2024-05-28 EDT | ||
| 9.93 EUR | +8.52% |
|
| Current month | -21.25% | ||
| 1 month | -22.90% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-28 | 9.93 | +8.52% |
| 24-05-27 | 9.15 | -1.19% |
| 24-05-24 | 9.26 | +1.54% |
| 24-05-23 | 9.12 | +4.35% |
| 24-05-22 | 8.74 | +1.39% |
Real-time BOERSE MUENCHEN
Last update May 28, 2024 at 02:26 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GG2D29 |
| ISIN | DE000GG2D296 |
| Date issued | 2024-01-10 |
| Strike | 406.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 9.41 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.79 € |
|---|---|
| Lowest since issue | 7.88 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
300.2
USD
Average target price
316.3
USD
Spread / Average Target
+5.36%
- Stock Market
- Certificates
- Certificat
